OTUS: New supercomputer at Paderborn University breaks records
Grant and Award Announcement
Updates every hour. Last Updated: 8-Nov-2025 09:11 ET (8-Nov-2025 14:11 GMT/UTC)
Fifth place in the international ‘Green 500’ rankings
142,656 processor cores, 108 GPUs, AMD processors from the latest ‘Turin’ generation and an IBM Spectrum Scale file system with five petabytes of storage capacity: these are the outstanding specifications of ‘Otus’, Paderborn University’s new supercomputer. Even before it is officially put into use in the third quarter of this year, it is already breaking records: at ISC in Hamburg, the international trade fair for high-performance computing (HPC), artificial intelligence, data analytics and quantum computing, the system was placed fifth in the ‘Green 500’ list of the world's most efficient computing systems. The ‘Green 500’ and ‘Top 500’ ranking lists serve as the benchmark for science and IT specialists. Whilst the ‘Top 500’ looks at speed alone, the ‘Green 500’ examines speed in relation to electrical power consumption. This enables energy efficiency to be measured.
In a paper published on aBIOTECH, the authors constructed G protein mutants using CRISPR/cas9 technology and investigated the biological functions of G proteins in growth, development, and symbiotic nodulation in Medicago truncatula.
Dr. Hye Jin Nam’s team at the Korea Research Institute of Chemical Technology (KRICT), in collaboration with Professors Dong Hyun Jo and Sangsu Bae at Seoul National University College of Medicine, found that autophagy induction via nutrient deprivation or mTOR inhibition markedly enhances the efficiency of HR-based CRISPR–Cas9 gene editing up to threefold.
Realizing the point-of-care tumor markers biodetection with good convenience and high sensitivity possesses great significance for prompting cancer monitoring and screening in biomedical study field. Herein, the quantum dots luminescence and microfluidic biochip with machine vision algorithm-based intelligent biosensing platform have been designed and manufactured for point-of-care tumor markers diagnostics. The employed quantum dots with excellent photoluminescent performance are modified with specific antibody as the optical labeling agents for the designed sandwich structure immunoassay. The corresponding biosensing investigations of the designed biodetection platform illustrate several advantages involving high sensitivity (~ 0.021 ng mL-1), outstanding accessibility, and great integrability. Moreover, related test results of human-sourced artificial saliva samples demonstrate better detection capabilities compared with commercially utilized rapid test strips. Combining these infusive abilities, our elaborate biosensing platform is expected to exhibit potential applications for the future point-of-care tumor markers diagnostic area.